Analyst: This Small-Cap Stock Could Triple

Analysts are overwhelmingly bullish on ECOR stock

Karee Venema

May 9, 2019 at 11:10 AM

ECOR

Noble Capital initiated coverage on electroCore, Inc. (NASDAQ:ECOR) with an "outperform" rating and $19 price target -- a 232% premium to last night's close at $5.71. The brokerage firm said the nerve stimulation specialist's gammaCore technology "is a compelling option for patients suffering from headache to provide pain relief," and could result in "higher market share ... in the billion-dollar pain market."

The bull note has failed to boost ECOR today, though, with the stock last seen down 4.9% at $5.61. This negative price action is just more of the same for an equity that's pacing for its sixth straight loss -- its longest losing streak since late October -- and has shed 68.8% since opening at $18 in its public trading debut back on June 22.

ecor stock daily price chart on may 9

Analysts overwhelmingly echo Noble Capital's upbeat assessment of ECOR stock, though, with 100% of those in coverage maintaining a "buy" or better rating. Plus, the average 12-month price target sits all the way up at $22.25.

Short sellers, on the other hand, have been actively betting against electroCore stock. Short interest has doubled year-to-date to 1.53 million shares. This represents more than one-fifth of ECOR's available float, or 9.3 times the average daily pace of trading.

Follow @Schaeffers

The $25K Day Trading Barrier is Gone

The long-standing Pattern Day Trader (PDT) rule that required many traders to maintain a $25,000 account balance is no longer standing in the way.

That means more traders can actively pursue short-term opportunities without the barrier that kept so many on the sidelines.

Now it's all about having the right strategy.

Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.

👉 Sign up now to receive the next trade